Dosage of Spiramycine 1.5 in details
Oral
Toxoplasmosis; Protozoal infections; Cryptosporidiosis; Susceptible infections
Adult: 6-9 million units/day in 2-3 divided doses, increased to 15 million units/day, given in divided doses for severe infections.
Child: and neonates: Chemoprophylaxis of congenital toxoplasmosis: 50 mg/kg bid.
Intravenous
Toxoplasmosis; Protozoal infections; Cryptosporidiosis; Susceptible infections
Adult: 1.5 million units by slow infusion every 8 hr, may double the dose in severe infections.
Spiramycine 1.5 interactions
may, in some people, induce more or less troublesome effects: Digestive Effects: Nausea, vomiting and diarrhea, occasionally requiring discontinuation of treatment. Allergic cutaneous reactions.
In order to avoid possible drug interaction, patient should always inform the doctor or pharmacist of any current treatment the patient is taking.
Reviews
The results of a survey conducted on ndrugs.com for Spiramycine 1.5 are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Spiramycine 1.5. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported frequency of use
No survey data has been collected yetConsumer reported doses
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
